Chas McKhann
CIK 1631746 · Chief Executive Officer · last filed 2026-04-17
Chas McKhann is a Chief Executive Officer who has filed 12 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for COCHW, was dated Apr 17, 2026. Across all open-market trades the lifetime net is −$1.0M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
12
-$1.01M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COCHW | Director | — | $0.05 | — | $0 | 1 | 2026-04-17 |
| Silk Road Medical Inc (SILK) Delisted | Chief Executive Officer | 1,299,042 | $27.49 | $35.71M | $0 | 3 | 2024-09-18 |
| Apollo Endosurgery, Inc. (APEN) Delisted | President and CEO | 0 | $10.00 | $0 | -$1.01M | 6 | 2023-04-04 |
| Intersect ENT, Inc. (XENT) Delisted | Chief Commercial Officer | — | $28.24 | — | $0 | 2 | 2016-01-20 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-17 | COCHW | Grant (A) | — | $0 | EDGAR |
| 2024-09-18 | Silk Road Medical Inc (SILK) Delisted | Mixed | −722,396 | $0 | EDGAR |
| 2024-03-05 | Silk Road Medical Inc (SILK) Delisted | Grant (A) | +110,313 | $0 | EDGAR |
| 2023-11-03 | Silk Road Medical Inc (SILK) Delisted | Grant (A) | +612,083 | $0 | EDGAR |
| 2023-04-04 | Apollo Endosurgery, Inc. (APEN) Delisted | Disp (D) | −689,880 | $0 | EDGAR |
| 2022-06-16 | Apollo Endosurgery, Inc. (APEN) Delisted | Grant (A) | +112,607 | $0 | EDGAR |
| 2022-05-09 | Apollo Endosurgery, Inc. (APEN) Delisted | Tax (F) | −66,553 | -$360.7K | EDGAR |
| 2021-08-20 | Apollo Endosurgery, Inc. (APEN) Delisted | Sell (S) | −63,452 | -$504.2K | EDGAR |
| 2021-08-20 | Apollo Endosurgery, Inc. (APEN) Delisted | Sell (S) | −63,452 | -$504.2K | EDGAR |
| 2021-03-12 | Apollo Endosurgery, Inc. (APEN) Delisted | Grant (A) | +707,278 | $0 | EDGAR |